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INTRODUCTION
Nucleophosmin (NPM1) is a ubiquitous nucleolar 
phosphoprotein that shuttles continuously between the 
nucleus and the cytoplasm [1, 2]. It is involved in a wide 
range of cellular functions, including ribosome biogenesis 
and transport, centrosome duplication, and cell cycle 
regulation (reviewed in [3]). NPM1 binds to a variety of 
cellular proteins, including p53 [4], Arf [5] and c-Myc [6] 
and controls their localization and stability.
Structural or functional abnormalities of NPM1 
are present in both solid tumors and hematological 
malignancies. Of particular relevance, about one third 
of acute myeloid leukemia (AML) cases are associated 
with mutations in the C-terminal region of the protein, 
which result in the loss of a nucleolar localization signal 
and the gain of a de novo nuclear export signal [7, 8]. 
Consequently, the mutant protein (NPMc+) is delocalized 
to the cytoplasm [8]. NPMc+ AML was recognized as 
a separate provisional entity in the 2008 revision of the 
World Health Organization classification of myeloid 
neoplasms and acute leukemia [9] since it possesses 
distinct features that include a specific gene expression 
profile, the association with a normal karyotype, the 
involvement of different hematopoietic lineages, and 
clinically, a favorable prognosis. 
Different animal models have been generated 
to investigate the causal relationship between NPMc+ 
expression and the development of AML [10]. Knockdown 
of endogenous npm1a in zebrafish embryos resulted 
in a reduction in the number of myeloid cells that was 
rescuable by human NPM1. Conversely, the expression 
of NPMc+ led to an expansion of primitive and definitive 
hematopoietic cells [11]. Ablation of the Npm1 gene in 
mice triggered early embryonic lethality, whereas animals 
expressing NPMc+ in the hematopoietic system developed 
a myeloproliferative disease [12] and leukemia [13, 14]. 
In particular, activation of a humanized NPMc+ knock-
in allele in the mouse hematopoietic system caused Hox 
gene overexpression, a feature shared with NPMc+ AML 
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ABSTRACT
Nucleophosmin (NPM1) is a ubiquitous multifunctional phosphoprotein with 
both oncogenic and tumor suppressor functions. Mutations of the NPM1 gene are 
the most frequent genetic alterations in acute myeloid leukemia (AML) and result in 
the expression of a mutant protein with aberrant cytoplasmic localization, NPMc+. 
Although NPMc+ causes myeloproliferation and AML in animal models, its mechanism 
of action remains largely unknown. Here we report that NPMc+ activates canonical 
Wnt signaling during the early phases of zebrafish development and determines a Wnt-
dependent increase in the number of progenitor cells during primitive hematopoiesis. 
Coherently, the canonical Wnt pathway is active in AML blasts bearing NPMc+ and 
depletion of the mutant protein in the patient derived OCI-AML3 cell line leads to a 
decrease in the levels of active β-catenin and of Wnt target genes. Our results reveal 
a novel function of NPMc+ and provide insight into the molecular pathogenesis of 
AML bearing NPM1 mutations.
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patients [15], and enhanced self-renewal and myelopoiesis. 
Importantly, one third of the animals developed late-
onset AML, suggesting that NPMc+ alone is insufficient 
for leukemic transformation and requires additional 
cooperating mutations [13]. In line with this hypothesis, 
mice carrying both the humanized NPMc+ allele and a 
knock-in allele coding for the FLT3-ITD mutation develop 
AML with short latency and full penetrance [16]. 
A common feature in AML is constitutive activation 
of the Wnt pathway, which plays a pivotal role in HSC 
maintenance and in the differentiation of blood cells 
[17, 18]. Canonical Wnt signalling is triggered by the 
interaction of a soluble Wnt ligand with a member of the 
Frizzled family of receptors, which results in stabilization 
and activation of β-catenin. Activated β-catenin enters the 
nucleus and binds to transcriptional co-activators of the 
TCF/LEF1 family inducing expression of target genes. 
In the absence of Wnt ligands, β-catenin is sequestered 
in a multiprotein cytoplasmic complex (“destruction” 
complex) and degraded in the proteasome [19, 20]. 
Inhibition of the canonical pathway can be achieved 
by expression of Dickkopf (Dkk) proteins, a group of 
secreted molecules that bind to Wnt receptors preventing 
their activation [21]. Signaling through Wnt pathway 
is required for different aspects of early embryonic 
development [22], including morphogenetic movements 
and cell type specification, and its deregulation leads to 
mislocalization of future adult tissues.
We found that the leukemogenic NPMc+ mutant 
activates canonical Wnt signaling during zebrafish 
development causing an expansion of the hematopoietic 
progenitor pool in primitive zebrafish hematopoiesis. 
Wnt signaling was indeed responsible for the 
myeloproliferative phenotype, since it was rescued by the 
overexpression of the dkk1b Wnt inhibitor. In addition, 
we established that canonical Wnt signaling is active in 
the patient derived OCI-AML3 cell line that expresses 
NPMc+ and in AML blasts expressing NPMc+.
Our study provides new insight into the molecular 
mechanisms underlying NPMc+ function, suggesting the 
involvement of Wnt activation in the establishment and/or 
the progression of NPMc+ AML. 
RESULTS
NPMc+ expression in zebrafish alters the 
morphology of developing embryos 
One-cell stage zebrafish embryos were injected with 
100 pg of in vitro transcribed mRNA representative of 
the most common NPM1 mutation (mutation A) or with 
120 pg of wild-type (wt) human NPM1. The morphology 
of the injected embryos was analyzed at 24 hours post 
fertilization (hpf). NPMc+ expression led to a general 
decrease in the body size and an enlargement of the 
hematopoietic region (Figure 1A), whereas expression 
of the wt NPM1 had a minimal or no effect (Figure 1A). 
Interestingly, the most affected embryos showed a strong 
posteriorization of the head, lacking the anterior part of the 
telencephalon, and presented defects in eye development 
(Figure 1B). Expression of NPMc+ protein in zebrafish 
embryos was confirmed by western blot (Figure 1C). 
Figure 1: Embryo morphology after NPM1 and NPMc+ expression in zebrafish embryos. (A) Overall view of control 
(uninjected), NPM1 (90% of injected embryos showing the reported phenotype) and NPMc+ (85% of injected embryos showing the 
reported phenotype in multiple experiments) expressing embryos at 24 hpf. (B) Head structures in control and NPMc+ expressing embryos 
at 24 hpf. (C) Western blot analysis of NPMc+ expression levels in zebrafish embryos.
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The phenotype observed upon NPMc+ expression 
resembled that of embryos bearing mutations that lead to 
the activation of Wnt signaling (wnt8, axin1), as reported 
in literature [23, 24], suggesting that injection of NPMc+ 
mRNA may result in an enhanced activity of the Wnt 
pathway. 
NPMc+ modulates CE movements during 
zebrafish gastrulation
The posteriorized phenotype observed upon NPMc+ 
expression could be caused by a block of convergence 
and extension (CE) movements during gastrulation, 
when the correct positioning of presumptive tissues is 
tightly regulated. In particular, the distance between the 
regions that will give rise to the eye/telencephalon and the 
mid-hindbrain boundary is controlled by canonical Wnt 
signaling [25]. We studied the consequences of NPMc+ 
expression on these CE movements by whole mount 
in situ hybridization experiments using a combination 
of probes that allow the identification of the two neural 
structures – the eye/telencephalon region characterized by 
the expression of rx3 and the mid-hindbrain border cells 
expressing pax2a at 90% epiboly (9 hpf) (Figure 2A, 2B). 
The expression of NPMc+ reduced the distance between 
the regions highlighted by the two probes, indicating a 
reduction of the interval between the eye/telencephalon 
and the mid-hindbrain border (Figure 2C). Conversely, 
the injection of 50 pg of zebrafish dkk1b mRNA, an 
inhibitor of the canonical Wnt pathway [21], led to a 
strong increase in the reciprocal distance between the 
two regions (Figure 2D). Co-injection of the two mRNAs 
partially rescued their respective effects (Figure 2E). 
The differences observed were statistically significant 
(Figure 2F). These results suggest that NPMc+ has the 
capacity to activate the canonical Wnt pathway during 
development of the anterior central nervous system in 
zebrafish, resulting in the deregulation of CE movements 
during gastrulation.
NPMc+ activates canonical Wnt signaling in 
zebrafish embryos
We next investigated if activation of Wnt signaling 
by NPMc+ is maintained in zebrafish embryos at later 
stages of development. The Tg(TOP:GFP) transgenic 
line, which bears the GFP reporter gene controlled by four 
enhancers and the basal promoter of lef1, a β-catenin-
dependent transcription factor [26], was used for this 
purpose. Tg(TOP:GFP) embryos were injected with 
NPMc+ mRNA or dkk1b mRNA. Due to the low level of 
fluorescence in transgenic embryos, GFP expression was 
revealed at 28 hpf using an anti-GFP antibody and DAB 
staining. Expression of NPMc+ increased the β-catenin 
signal (Figure 3A, 3B) whereas dkk1b strongly decreased 
the GFP signal (Figure 3C). Co-injection of dkk1b 
and NPMc+ mRNAs rescued the signal (Figure 3D), 
suggesting that activation of canonical Wnt signaling 
by NPMc+ is maintained at later stages of zebrafish 
development.
Figure 2: Analysis of CE movements at gastrulation. Whole mount in situ hybridization for rx3 and pax2a markers of the eye 
field and telencephalon region (et) and mid-hindbrain boundary (mhb), respectively. All embryos are at 90% epiboly, dorsal view. Distance 
between rx3 and pax2a expression regions was measured with ImageJ; statistical significance was assessed with a Student’t test. (A) 
Schematic representation of areas of markers expression. (B) Representative example of uninjected control. Embryos injected with: (C) 
NPMc+ mRNA; (D) dkk1b mRNA; (E) NPMc+ and dkk1b mRNAs. (F) Graphic representation of the distance between rx3 and pax2a 
expression regions for each measured sample (20 embryos were analyzed for each condition).
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The increase of hematopoietic progenitors after 
NPMc+ expression is Wnt-dependent 
Since the NPMc+ mutant is specific of AML, 
we next studied the hematopoietic compartment 
during development. In zebrafish two distinct waves 
of hematopoiesis occur, i.e. primitive hematopoiesis, 
characteristic of embryonic stages, and definitive 
hematopoiesis that gives rise to blood cells in the adult 
animal. During primitive hematopoiesis, common 
precursors of hematopoietic and endothelial cells 
(hemangioblasts) appear at two different sites: the 
anterior lateral mesoderm (ALM) and the posterior 
lateral mesoderm (PLM). Later on during development, 
the two stripes of the PLM converge and give rise to the 
intermediate cell mass (ICM) while a transient wave of 
hematopoiesis occurs in the posterior blood island (PBI) 
[27]. In the ICM, progenitors give rise predominantly 
to erythrocytes, whereas in the PBI only a transient 
population of myeloid cells emerges. At 28–30 hpf, 
primitive mature leukocytes can be observed respectively 
in the ICM and PBI regions and throughout the body, 
while differentiated erythrocytes are dispersed in the 
embryo blood. 
Whole mount in situ hybridization experiments 
were performed with the aim of analyzing the expression 
of known hematopoietic markers in zebrafish embryos 
expressing NPMc+. Since anterior structures may be 
deformed or absent in severely posteriorized embryos, 
therefore skewing the evaluation of hematopoietic cell 
numbers in the ALM, the analysis was restricted to the 
posterior structures (Figure 4A). Hematopoietic markers 
were analyzed at different time points according to their 
expression pattern: gata2, tal1 and lmo2 were evaluated 
in early hematopoietic progenitors, spi1 (pu.1) in myeloid 
progenitors, gata1 in cells of the erythroid lineage and 
lcp1 and mpx (mpo) in differentiated myeloid cells [27]. 
A detailed scheme of the markers used in this study and a 
timeline of their expression during zebrafish development 
is shown in Figure 4B.
The injection of NPMc+ into one-cell stage embryos 
led to an increase in the expression of gata2 at 16 hpf, 
and of tal1 and lmo2 at 24 hpf, revealing an expansion 
of the pool of primitive progenitors in the PLM and in 
the ICM (Figure 4C). The hybridization signals were, 
instead, faint for all three markers in dkk1b overexpressing 
embryos (Figure 4C). Co-injection of dkk1b and NPMc+ 
mRNA rescued the phenotype in all cases (Figure 4C), 
suggesting that the effect elicited by NPMc+ depends on 
the activation of Wnt signaling.
Next, primitive myeloid precursors, characterized by 
expression of the pu.1 transcription factor [27] transcribed 
from the spi1 gene, were studied at 16 hpf. As expected, 
the pool of spi1 positive cells increased in NPMc+ injected 
embryos. Conversely, the number of these cells decreased 
in dkk1b overexpressing embryos (Figure 4C). Moreover, 
the injection of dkk1b mRNA led to the dispersion of 
the few spi1 positive cells in the posterior region of the 
embryos and the co-injection of NPMc+ with dkk1b only 
partially rescued the phenotype (Figure 4C). It appears, 
Figure 3: Canonical Wnt activation in 28 hpf embryos. DAB-staining for GFP expression in TOP:GFP embryos at 28 hpf. 
Embryos are shown in dorsal view. (A) uninjected control (32/32). Embryos injected with: (B) NPMc+ mRNA (27/28); (C) dkk1b mRNA 
(32/32); (D) NPMc+ and dkk1b mRNAs (16/22).
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therefore, that the previously reported increase in the pool 
of myeloid precursors upon NPMc+ expression [11], as 
defined by spi1 positivity at early stages of development, 
is partially reversible by Wnt signaling inhibition. 
To assess if the increase of progenitor cells observed 
at 16 hpf and 24 hpf corresponds to the expansion of 
mature blood cells, we performed in situ hybridization 
experiments using markers of differentiated cells. 
In NPMc+ injected embryos, the pool of leukocytes 
(lcp1+) was similar to uninjected controls and was also 
not modified by the injection of dkk1b mRNA or the 
combination of the two mRNAs (Figure 4C). A similar 
pattern was observed when analyzing the granulocytes 
in mpo:GFP transgenic embryos (data not shown). The 
expansion of the pool of hematopoietic progenitors was, 
therefore, not strictly connected to an increase in the 
number of more differentiated cells. 
The effect of NPMc+ on erythropoiesis was 
investigated in gata1:dsRED embryos. Gata1 expression 
levels were not modified by NPMc+ mRNA expression 
at 24 hpf (Supplementary Figure S1), suggesting that 
the erythroid lineage is not altered by the presence of 
the leukemogenic mutant. On the contrary, the injection 
of dkk1b mRNA had a strong negative effect, with a 
considerable decrease of the gata1+ cells (Supplementary 
Figure S1). The co-injection of the two mRNAs enhanced 
the expression of gata1 compared to dkk1b alone, but 
positive cells were more concentrated in the primitive 
Figure 4: Expression of hematopoietic markers during early zebrafish hematopoiesis. (A) Schematic representation of 
primitive hematopoietic organs in zebrafish embryos as seen in posterior (top) and lateral (bottom) views showing PLM (posterior lateral 
mesoderm), ICM (intermediate cell mass) and PBI (posterior blood island). (B) Timeline of expression of hematopoietic markers expressed 
in the posterior hematopoietic region of zebrafish embryos during primitive hematopoiesis. (C) Whole mount in situ hybridization for gata2 
(15 somites embryos, dorsal and posterior view. The phenotypes were encountered in a number of embryos as detailed for each marker 
hereafter. Control: 41/41, NPMc+: 29/32, dkk1b: 31/31, NPMc+ and dkk1b: 20/27), tal1 and lmo2 (24 hpf embryos, lateral view. For tal1: 
control: 51/52, NPMc+: 65/85, dkk1b: 30/43, NPMc+ and dkk1b: 17/34. For lmo2: control: 44/45, NPMc+: 33/34, dkk1b: 27/33, NPMc+ 
and dkk1b: 24/33), spi1 (15 somites embryos, dorsal and posterior view. Control: 32/32, NPMc+: 21/23, dkk1b: 33/34, NPMc+ and dkk1b: 
22/28), lcp1 (30 hpf embryos, lateral view. Control: 23/24, NPMc+: 26/28, dkk1b: 25/25, NPMc+ and dkk1b: 30/37). 
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hematopoietic region (Supplementary Figure S1), 
confirming that NPMc+ partially rescues the effect of 
overexpression of dkk1b in zebrafish embryos.
In conclusion, these experiments showed that 
NPMc+ expression led to an expansion of the pool of 
progenitor cells during primitive zebrafish haematopoiesis 
and this effect was rescued by overexpression of the Wnt 
inhibitor dkk1b.
NPMc+ silencing in AML-OCI3 cells leads 
to a decrease in active β-catenin and AXIN2 
expression levels
Activation of Wnt signaling has been reported in 
AML blasts expressing leukemogenic fusion proteins 
[17, 28, 29] but has not been described, to date, in 
NPMc+ AML. On the basis of our results in zebrafish, we 
investigated Wnt signaling activation in the OCI-AML3 cell 
line, which was derived from a patient with NPMc+ AML. 
A significant reduction of NPMc+ expression was 
achieved after transduction of OCI-AML3 cells with a 
short-hairpin RNA that specifically targets the NPM1 
mutant (Figure 5A top panel and 5B). The levels of wild 
type NPM1 protein were not modified by this treatment 
(Figure 5A bottom panel). Expression of total β-catenin 
was slightly increased after NPMc+ depletion, whereas 
the levels of active β-catenin (Figure 5B) and of the Wnt 
targets AXIN2 (Figure 5A) and CyclinD1 (not shown) 
decreased significantly. This result suggests that NPMc+ 
expression correlates with the activation of canonical Wnt 
signaling in OCI-AML3 cells.
Blasts from patients with NPMc+ AML show 
activation of the canonical Wnt pathway
 Next, we analyzed by immunofluorescence the 
subcellular localization of β-catenin on bone marrow 
smears from a series of AML patients. First, a polyclonal 
antibody that recognizes all forms of β-catenin was used. 
Four out of six patients (67%) bearing NPM1 mutations 
and two out of nine patients (22%) with wild-type NPM1 
displayed a variable proportion of β-catenin in the nucleus 
(Figure 6A). An antibody that specifically recognizes the 
active form of β-catenin (anti-ABC) revealed nuclear 
staining in six out of seven patients (87%) with NPM1 
mutations and two out of seven patients (29%) with 
wild-type NPM1 (Figure 6B). In some cases, anti-ABC 
disclosed a staining pattern restricted to the nucleus, such 
as that shown in the right hand panels of Figure 6A and 6B 
representing cells from the same patient stained with the 
two antibodies. Finally, we used the anti-ABC antibody in 
conjunction with an antibody against NPMc+ (Figure 6C) 
and found that cells with high levels of NPMc+ displayed 
a nuclear localization of β-catenin. 
Figure 5: Expression of AXIN2 and active β-catenin in OCI-AML3 cells after silencing NPMc+. (A) Transduction of 
shNPMc+ in OCI-AML3 cells results in approximately 50% reduction of NPMc+ protein levels (top panel), but does not affect NPM1 
expression (bottom panel). Expression of AXIN2 decreases in shNPMc+ treated OCI-AML3 cells. (B) Total β-catenin levels remained 
unaltered after NPMc+ silencing whereas active β-catenin expression decreases proportionally to NPMc+. Western blots in A and B were 
generated using lysates from different transduction experiments. The top and bottom panels in A correspond to different gels produced 
with the same lysates. Numbers below the lanes correspond to the relative quantity of each protein in shNPMc+ treated cells compared to 
controls, normalized using α-tubulin expression. Images were analyzed and quantified with ChemiDoc™ MP system software (BioRad).
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mRNA levels of the Wnt target gene AXIN2 [30] 
were analyzed by qPCR in blasts from 40 AML patients 
with normal karyotype (30 with NPM mutations and 
10 without) and in normal hematopoietic cells (CD34+ 
progenitors, monocytes and granulocytes, Figure 7). 
Compared to CD34+ precursors, AXIN2 levels were higher 
in more differentiated cells (1.6-fold in granulocytes and 
3.3-fold in monocytes, respectively). In 27/30 NPMc+ 
AML patients (90%) AXIN2 levels were increased by 
>2-fold when compared to CD34+ cells. 26/30 cases 
(87%) displayed increased AXIN2 levels compared to 
granulocytes, and 22/30 (73%) compared to monocytes. 
AML with normal karyotype without NPM1 mutations also 
displayed increased expression of AXIN2 in 10/10 cases 
(100%) when compared to CD34+ cells, 7/10 cases (70%) 
compared to granulocytes, and 6/10 (60%) compared to 
monocytes. There was no correlation between AXIN2 
levels and concurrent mutations in other genes that are 
frequently mutated in AML such as FLT3, IDH1, IDH2, 
DNMT3a, N-RAS and K-RAS (Supplementary Table S1). 
It appears, therefore, that canonical Wnt signaling 
is activated in most cases of AML with normal karyotype. 
The mechanism of Wnt activation in AML without NPM 
mutations remains to be identified.
DISCUSSION
A myeloproliferative effect of NPMc+ has been 
described both in zebrafish [11] and mouse [12]. Our study 
shows that, in zebrafish, this effect derives from activation 
of Wnt signaling by NPMc+, since co-expression of dkk1b 
rescued the phenotype. Interestingly, NPMc+ only affects 
precursors without expanding the pool of mature myeloid 
cells in primitive hematopoiesis. This discrepancy can be 
Figure 6: Analysis of β-catenin localization in AML patients. (A) Summary of results obtained with an antibody that recognizes 
total β-catenin (Sigma) and examples of staining patterns: cytoplasmic (left panels) and mostly nuclear (right panels). (B) Summary 
of results obtained with an antibody that specifically recognizes active β-catenin (ABC) (Millipore) and examples of staining patterns: 
cytoplasmic (left panels) and mostly nuclear (right panels). (C) Example of a co-staining performed on a BM smear of an NPMc+ AML 
patient showing strong nuclear ABC signal in a cell that expresses high levels of NPMc+. Staining with anti β-catenin, anti-ABC or anti-
NPMc+, DAPI staining and merged channels (Merge) are shown at magnification of x600. 
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explained by the dose-dependent sensitivity of different 
hematopoietic cells to Wnt activation [18]. In fact, HSC 
are stimulated to proliferate with mild levels of Wnt 
activation, while in the presence of a potent activation 
the HSC pool is depleted and myeloid differentiation is 
enhanced [18]. Activation of the Wnt pathway by NPMc+ 
may be sufficient to trigger proliferation of progenitor cells 
but insufficient to elicit an effect on the differentiation of 
myeloid cells. 
Canonical Wnt signaling is known to be active in 
HSC [31] and in AML expressing specific oncogenes 
such as MLL-AF9, AML1-ETO and PML-RARα 
[17, 28, 29]. We found that Wnt signaling is also active in 
blasts derived from patients bearing NPM1 mutations as 
indicated by the nuclear accumulation of active β-catenin 
and overexpression of one of its target genes, AXIN2. This 
finding suggests that NPMc+ may be responsible for Wnt 
signaling activation in an AML subtype without known 
translocation products. Interestingly, it has been previously 
suggested that leukemic stem cells strictly depend on the 
integrity and activation of the Wnt pathway whereas 
adult HSC do not require β-catenin for self-renewal [29]. 
Clearly, such difference may offer an opportunity for new 
therapeutic approaches in AML including the NPMc+ 
AML subtype.
Zebrafish embryos expressing NPMc+ showed 
a morphology that suggests an impairment in the 
formation of the anteroposterior axis, a function that 
involves modulation of Wnt signaling. In the definition of 
anteroposterior identity, an important role is also played 
by Hox genes and their upstream modulators, including 
the caudal-related (Cdx) genes. Interestingly, zebrafish 
mutants for Cdx genes have a bloodless phenotype, 
revealing their importance in directing mesodermal cells 
toward the hematopoietic fate [32], and canonical Wnt 
signaling has been shown to activate the Cdx/Hox axis 
[33]. The characteristic increase in Hox gene expression 
found in NPMc+ AML [15] may, therefore, partly derive 
from activation of canonical Wnt signaling. 
In conclusion, we describe a novel function of 
NPMc+, the leukemogenic mutant of nucleophosmin, 
namely, activation of the canonical Wnt pathway leading 
to an expansion of the pool of primitive hematopoietic 
progenitors in a Wnt-dependent manner. 
Figure 7: Analysis of AXIN2 expression in AML patients. mRNA levels of the Wnt target AXIN2 were assessed by qPCR in a 
series of patients with AML with normal karyotype versus normal controls (CD34+ cells, granulocytes and monocytes). Patients 1–30 have 




Tübingen wild-type and transgenic 
Tg(gata1:dsRED) [34], Tg(mpx:GFP) [35], Tg(TOP:GFP) 
[26] zebrafish strains were maintained and bred according 
to standard procedures [36].
RNA injection
Zebrafish dkk1b, human NPM1 and NPMc+ cDNAs 
were cloned into pCS2+ plasmid. 10 µg of each construct 
were digested with NotI, purified and in vitro transcribed 
using the mMessage mMachine SP6 kit (Ambion) to generate 
capped RNAs. Zebrafish embryos were microinjected in the 
yolk or in the cell at 1-cell stage using a combination of the 
following: 120 pg synthetic human NPM1 mRNA, 100 pg 
of NPMc+ mRNA and 50 pg of dkk1b mRNA.
Whole-mount in situ hybridization and 
immunostaining
The RNA probes for in situ hybridization were 
synthesized as follows: 1 μg of each vector was linearized 
with the corresponding restriction enzyme and in vitro 
transcribed with T7, T3 or SP6 RNA polymerase (for 
specific restriction condition see Supplementary Table 
S2). Next, RNA probes were labeled with digoxigenin 
(DIG) using DIG-RNA labeling mix (Roche). Embryos 
were fixed overnight at 4°C with 4% paraformaldehyde 
in PBS solution. Whole mount in situ hybridization was 
performed as previously described [37]. 
In Tg(TOP:GFP) transgenic embryos, GFP 
expression was revealed with an antibody against GFP 
(TP401, Torrey Pines Biolabs) and subsequently by 
colorimetric reaction using peroxidase, conjugated to the 
secondary antibody, and DAB (3,3ʹ-Diaminobenzidine). 
Embryos were then included in 85% glycerol, flat-
mounted and viewed with a Nikon stereomicroscope.
Western blot
Zebrafish embryos at 24 hpf were lysed in SDS 
buffer, a mixture of 1 part of buffer I (150 mM Tris-HCl 
pH6.8, 30% glycerol and 5%SDS) and 3 parts of buffer 
II (25 mM Tris-HCl pH 8.3, 50 mM NaCl, 0.5% NP-40, 
0.5% sodium deoxycholate, 0.1% SDS) with proteases 
inhibitors. 50 μg of each sample were loaded on a SDS-
PAGE gel and presence of NPMc+ was detected using T26 
antibody [38]. Anti-human tubulin (Sigma-Aldrich) was 
used as loading control.
Interference anti-NPMc+ in OCI-AML3 cell line
OCI-AML3 cells, which express NPMc+ mutant 
protein (mutant A) were transduced with pSicoPuroR 
lentiviral vector expressing a short hairpin anti-NPMc+-
mutant A (target sequence: 5ʹ-gatctctgtctggcagtgg-3ʹ). 
Following selection in puromycin (2 μg/ml), cells were 
lysed directly in 1 × Laemmli buffer (2% SDS, 10% 
glycerol, 5% 2-mercaptoethanol, 0.002% bromphenol 
blue and 0.0675 M Tris HCl, pH approx. 6.8) and 
resolved on SDS-PAGE gel of appropriate density. T26 
antibody was used to detect NPMc+, while NPM1 was 
detected using a monoclonal antibody that recognizes 
specifically C-terminus of the protein (NPMc, [39]). 
Total β-catenin was detected using murine monoclonal 
antibody anti-β-catenin (Clone 14/β-catenin, BD). Active 
β-catenin was identified using a rabbit phospho-β-catenin 
(Ser552) (Cell Signaling). Such phosphorylation induces 
the accumulation of β-catenin in the nucleus where 
is binds to its target genes. AXIN2 was detected by a 
rabbit monoclonal antibody anti-Axin2 [EPR2005(2)]. 
An antibody anti-α-tubulin (Sigma-Aldrich) was used as 
a loading control. Images of blots were acquired using 
the ChemiDoc™ MP system (Bio-Rad) and analyzed/
quantified using the built-in software. 
Patients’ samples, immunofluorescence, qPCR 
and common mutation screening
For immunofluorescence experiments, bone marrow 
smears from 40 patients at diagnosis were obtained from 
the Hematology Department of the Tor Vergata University 
(Rome, Italy). Bone marrow samples were taken upon 
patients’ informed consent and the Internal Review Board 
approved this research. Immunofluorescence staining was 
performed on smears fixed in 4% paraformaldehyde and 
permeabilized with 0.1% Triton X 100/0.2% BSA/PBS, 
as previously described [38]. The following antibodies 
were used: polyclonal anti-total β–catenin (Sigma) diluted 
1:2000, anti-active β–catenin (ABC, Millipore) diluted 
1:200 alone or together with a polyclonal antibody anti-
NPMc+ (custom-made by Eurogentech) diluted 1:1000. 
Slides were analyzed with Olympus BX61 fluorescent 
microscope equipped with CoolSNAP EZ camera 
(Photometrics, Tucson, USA). Single colour images were 
taken with the Metapmorph software; overlay of different 
fluorescence channels and pseudocolor assignment was 
performed with ImageJ (Wayne Rasband, NIH, USA).
AXIN2 expression (forward primer: 5ʹ-ACAACAG 
CATTGTCTCCAAGCAGC-3ʹ, reverse primer: 5ʹ-GCGC 
CTGGTCAAACATGATGGAAT-3ʹ) was analyzed in RNA 
from blasts of 30 AML patients bearing NPM1 mutations 
and 10 AML patients with normal karyotype and no 
NPM1 mutations using SybrGreen technology (for genetic 
characteristics see Supplementary Table S1) with TBP as 
a  housekeeping control (forward primer: 5ʹ-CGGCTG 
TTTAACTTCGCCTTC-3ʹ, reverse primer: 5ʹ-CACACGC 
CAAGAAACAGTGA-3ʹ). Normal CD34+ progenitors, 
granulocytes and monocytes were included as control.
RNA samples from all patients were screened for 
the common AML mutations at known hotspots by direct 
Oncotarget10www.impactjournals.com/oncotarget
Sanger sequencing of PCR products. The primers used for 
the screening are given in Supplementary Table S3.
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